LUND, Sweden, May 21, 2024 /PRNewswire/ –. Hansa Biopharma, “Hansa” (NASDAQ: HNSA) (STOCKHOLM: HNSA), today announced data featuring imlifidase will be presented at the American Transplant Congress (ATC), the joint annual meeting of the American Society of Transplant Surgeons (ASTS) and…